XML 52 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Financial assets and liabilities measured at fair value on a recurring basis
The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2012:
 
 
Fair Value Measurements at
 
December 31, 2012
 
Total
 
Using Quoted Prices
in Active Markets
for Identical Assets
(Level 1)
 
Using Significant
Other Unobservable
Inputs
(Level 2)
 
Using Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Money market funds
$
1,686,406

 
$
1,686,406

 


 
$

Mutual funds
7,583,931

 

 
7,583,931

 

Certificates of deposit
250,000

 

 
250,000

 

Municipal bonds
200,070

 

 
200,070

 

Investment in affiliated entity
10,703,332

 
10,703,332

 

 

Common stock warrants
267,200

 

 

 
267,200

Total Assets
$
20,690,939

 
$
12,389,738

 
$
8,034,001

 
$
267,200

Liabilities:
 
 
 
 
 
 
 
Common stock warrants
$
2,859,899

 
$

 
$

 
$
2,859,899

Total Liabilities
$
2,859,899

 
$

 
$

 
$
2,859,899


The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2011:
 
 
Fair Value Measurements at
 
December 31, 2011
 
Total
 
Using Quoted Prices
in Active Markets
for Identical Assets
(Level 1)
 
Using Significant
Other Unobservable
Inputs
(Level 2)
 
Using Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Money market funds
$
16,330,885

 
$
16,330,885

 
$

 
$

Mutual funds
6,037,115

 

 
6,037,115

 

Certificates of deposit
5,768,304

 

 
5,768,304

 

Municipal bonds
1,058,001

 

 
1,058,001

 

Investment in affiliated entity
9,071,513

 
9,071,513

 

 

Common stock warrants
100,000

 

 

 
100,000

Total Assets
$
38,365,818

 
$
25,402,398

 
$
12,863,420

 
$
100,000

Liabilities:
 
 
 
 
 
 
 
Common stock warrants
$
5,176,319

 
$

 
$

 
$
5,176,319

Total Liabilities
$
5,176,319

 
$

 
$

 
$
5,176,319

Assumptions used to estimate the fair values of the common stock warrants
The range of assumptions used to estimate the fair values of common stock warrants at December 31, 2012 are presented below:
 
Risk-free interest rate
0.18%-0.36%
Expected volatility
61%-116%
Expected life in years
1.5-3.93
Dividend yield
Change in fair value of the financial assets
The following table presents a summary of changes in fair value of the Company’s total Level 3 financial assets for the years ended December 31, 2012 and 2011:

 
Year Ended
 
Year Ended
 
December 31, 2012
 
December 31, 2011
Balance at beginning of year
$
100,000

 
$

Common stock warrant recorded at fair value upon acquisition
501,000

 
237,000

Decrease in fair value included in change in fair value of common stock warrants
(333,800
)
 
(137,000
)
Balance at end of year
$
267,200

 
$
100,000



Changes in fair value of the financial liabilities
The following table presents the changes in fair value of the Company’s total Level 3 financial liabilities for the years ended December 31, 2012 and 2011:
 
 
Year Ended
 
Year Ended
 
Year Ended
 
December 31,
2012
 
December 31,
2011
 
December 31, 2010
Balance at beginning of year
$
5,176,319

 
$
370,926

 
$
2,774,850

Record fair value of warrants issued in January 2011 financing

 
11,727,372

 

Record fair value of warrants issued in December 2011 financing

 
1,905,679

 

Decrease in fair value included in change in fair value of common stock warrants
(2,316,420
)
 
(8,827,658
)
 
(2,403,924
)
Balance at end of year
$
2,859,899

 
$
5,176,319

 
$
370,926

OncoSec [Member]
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Assumptions used to estimate the fair values of the common stock warrants
The assumptions used to estimate the fair values of the OncoSec common stock warrants at December 31, 2012 are presented below:

Risk-free interest rate
0.36%
Expected volatility
85%
Expected life in years
3.75-4.25
Dividend yield